Abstract

The enantioselective synthesis of fluorinated indolizidinone derivatives has been developed. The process involved an enantioselective intramolecular aza-Michael reaction of conjugated amides bearing a pendant α,β-unsaturated ketone moiety, catalyzed by the (S)-TRIP-derived phosphoric acid, followed by dimethyltitanocene methylenation and ring closing metathesis (RCM). Final indolizidine-derived products comprise a fluorine-containing tetrasubstituted double bond generated by the RCM reaction, which is a challenging task. The whole synthetic sequence took place in acceptable overall yields with excellent enantioselectivities.
The indolizidine scaffold is a widespread motif in a broad variety of alkaloids arising from extremely diverse natural sources. This type of chemical skeleton belongs to the izidine family, which constitutes ∼30% of the known alkaloids. Natural and non-natural indolizidines display a wide range of biological activities,1 and their pharmacological potential has made them privileged structures in medicinal chemistry research. The development of methodologies that gain access to those skeletons, especially in an asymmetric manner, is highly desirable and has attracted considerable attention from the synthetic chemistry community.2
The benefits of introducing fluorine atoms into organic molecules have been well recognized in the field of medicinal chemistry.3 Thus, fluorine substituents usually improve membrane permeability, metabolic pathways, and pharmacokinetic properties of the parent nonfluorinated molecules. As a consequence, fluorine-containing drugs account for >20% of all pharmaceuticals currently marketed.4 Moreover, some of the so-called blockbuster drugs contain fluorine atoms in their structures.5 Despite the abundance of fluorine in the Earth’s crust, its presence in biological systems is minimal and fluoroorganic compounds are mostly man-made. A wide variety of reagents for the selective introduction of fluorine or fluoroalkyl groups into specific locations of organic molecules have been devised, providing the chemistry community with the toolbox for the synthesis of tailor-made fluoroorganic derivatives. In the context of indolizidine scaffolds, despite their biological relevance, those bearing fluorinated substituents are very scarce.6
The first asymmetric synthesis of trifluoromethylated indolizidines was reported in 2002 by Okano and co-workers through a diastereoselective radical cyclization.7 Subsequently, the group of Kim performed an asymmetric synthesis of trifluoromethyl monomorine using a diastereoselective hydrogenation of a chiral fluorinated oxazoline as the key step.8 The synthesis of gem-difluoromethylene-containing indolizidines was carried out by Pohmakotr and co-workers by means of a fluoride-catalyzed nucleophilic addition of PhSCF2SiMe3 to chiral imides9 and nitrones,10 followed by intramolecular radical cyclization. In 2014, the group of Haufe reported the synthesis of a monofluorinated indolizidine from (S)-N-Boc-2-allyl pyrrolidine using a ring closing metathesis (RCM) reaction.11 Finally, Cordero and Brandi synthesized fluorinated analogues of the 1,2-dihydroxyindolizidine natural product lentiginosine.12
To date, all of the reported methodologies for accessing chiral nonracemic fluorinated indolizidines are based on either chiral pool or chiral auxiliary strategies. Alternatively, we devised a highly convenient enantioselective synthetic strategy that provides entry to enantiomerically enriched fluorinated indolizidinones in a three-step sequence. In the approach we described here, the six-membered ring was disconnected at the double bond by means of a RCM reaction on diolefinic pyrrolidines 4, in turn prepared from chiral pyrrolidines 3 through carbonyl olefination. The chiral center was settled by an enantioselective intramolecular aza-Michael reaction (IMAMR) on conjugated amides 2 bearing a remote α,β-unsaturated ketone moiety (Scheme 1).
Scheme 1. Strategy Devised for the Enantioselective Synthesis of Fluorinated Indolizidines.
The starting fluorinated conjugated amides 2, conveniently functionalized to carry out the intended synthetic strategy, were obtained by means of a selective cross-metathesis reaction between fluorinated amides 1 and conjugated ketones 6 in the presence of a Hoveyda–Grubbs second-generation catalyst (HG-II). Compounds 1 were in turn prepared from reduction of the corresponding nitriles followed by coupling with 2-fluoroacrylic acid or 2-(trifluoromethyl)acryloyl chloride (Scheme 2; see the Supporting Information for details).
Scheme 2. Synthesis of Fluorinated Conjugated Amides 2.
The feasibility of the proposed synthetic methodology was explored with α-fluoroacrylamide 2a as a model substrate. The results of the optimization of the enantioselective intramolecular aza-Michael reaction (IMAMR) are summarized in Table 1. Initially, the reaction was evaluated with hydroquinine-derived primary amine I and trifluoroacetic acid as a co-catalyst, because this catalytic system usually provides good results for conjugated additions to enones13 (Table 1, entry 1); however, the reaction did not proceed, probably due to the low nucleophilicity of amides. Then, we moved to Brønsted acid catalysis, because previous results from our group had indicated that chiral BINOL-derived phosphoric acids (CPAs) were suitable catalysts for the IMAMR when amides were used as nitrogen sources.14,15
Table 1. Optimization of the Enantioselective Cyclization of Substrate 2a by an Intramolecular Aza-Michael Reactiona.
| entry | catalyst | solvent | yieldb (%) | ee (%)c |
|---|---|---|---|---|
| 1 | I/TFA | CHCl3 | – | – |
| 2 | II | CHCl3 | 79 | 23 |
| 3 | III | CHCl3 | 99 | 32 |
| 4 | IV | CHCl3 | 86 | 95 |
| 5 | IV | CHCl3 | 87 | 94d |
| 6 | IV | toluene | 90 | 92 |
| 7 | IV | THF | 13 | 98 |
| 8 | V | CHCl3 | 82 | 33 |
Reactions were performed with 2a (0.2 mmol) and a catalyst (10 mol %) in a dry solvent.
Isolated yields after flash column chromatography.
Enantiomeric ratios were determined by HPLC analysis on a chiral stationary phase (see the Supporting Information for details).
Reaction performed at 60 °C.
Therefore, CPA II was tested, and the reaction afforded chiral pyrrolidine 3a in 79% isolated yield but with a low enantiomeric excess (23%) (Table 1, entry 2). Changing the catalyst to anthracenyl-derived CPA III provided an excellent chemical yield of product 3a, although, again, poor enantiocontrol (32% ee) (Table 1, entry 3). Fortunately, with (S)-TRIP-derived catalyst IV, the cyclization reaction took place in good yield (86%) with excellent enantioselectivity (95% ee) at room temperature (Table 1, entry 4). When the reaction was performed at 60 °C, comparable results were obtained in terms of yield and enantiocontrol (Table 1, entry 5), while the use of other solvents such as toluene or THF was detrimental with respect to the enantioselectivity or the chemical yield (Table 1, entry 6 or 7, respectively). Finally, when the more acidic triflimide V was employed, a remarkable decrease in the enantioselectivity was observed (Table 1, entry 8). In light of these results, the optimal conditions for the IMAMR of α-fluoroacrylamide 2a involved its treatment with (S)-TRIP-PA IV (10 mol %) as the catalyst in chloroform at room temperature (Table 1, entry 4).
These reaction conditions were further extended to other starting fluorinated amides 2, and the results are summarized in Scheme 3.
Scheme 3. Scope of the Enantioselective Intramolecular Aza-Michael Reaction–
Unless otherwise noted, reactions were carried out with 2 (0.2–0.5 mmol) and catalyst IV (10 mol %) in chloroform (2 mL) at room temperature for 36 h.
Isolated yields after flash column chromatography.
Enantiomeric ratios were determined by HPLC analysis on a chiral stationary phase (see the Supporting Information for details).
With regard to the vinyl ketone moiety, both aliphatic (2a–c) and aromatic (2d) conjugated ketones readily underwent the IMAMR, providing the corresponding fluorinated 4,4-dimethyl pyrrolidines 3a–d, respectively, in excellent yields and enantioselectivities. Other modifications of the starting fluorinated conjugated amides 2 were also possible. Thus, pyrrolidines (3e–j) bearing spirocyclic moieties at position 4 such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, tetrahydropyranyl, and N-Boc piperidinyl were obtained very efficiently. Likewise, 4-unsubstituted pyrrolidine 3k and 4,4-diphenyl derivative 3l were obtained in excellent (97%) and moderate (52%) yield, respectively, albeit with diminished enantioselectivity (79% and 71% ee, respectively). Benzo-fused substrates were also tolerated in this enantioselective cyclization, rendering 2-substituted indoline derivatives 3m–o in moderate isolated yields and good ee values. Finally, α-trifluoromethyl acrylamide 2p gave rise to the corresponding trifluoromethylated pyrrolidine 3p in excellent yield and 85% ee (Scheme 3).
The absolute configuration of the newly created stereocenter in the IMAMR was assigned by X-ray analysis. Crystals of pyrrolidine 3p suitable for single-crystal X-ray diffraction displayed the R absolute configuration,16 and an identical stereochemical outcome was assumed for all other pyrrolidines 3.
With enantiomerically enriched fluorinated pyrrolidines 3 in hand, the next step of our study was the methylenation of the ketone carbonyl to subsequently effect the RCM reaction that would complete the indolizidine skeleton. The first attempt was made with compound 3a as the model substrate and involved its treatment with Wittig ylide Ph3P=CH2; however, no reaction took place, but racemic substrate (±)-3a was isolated instead of the expected methylenation product (Scheme 4, eq 1). This racemization event could be explained considering that the IMAMR is a reversible process. The Wittig ylide would act as a base, promoting the retro-Michael/Michael sequence that would afford racemic product (±)-3a.
Scheme 4. Methylenation/RCM Sequence on Fluorinated Pyrrolidine 3a.
To avoid this disappointing result, we consider the use of dimethyltitanocene17 (Cp2TiMe2, Petasis reagent) as an alternative to perform the desired carbonyl methylenation. This reagent would work by heating in toluene in the absence of a base, which would prevent the undesired retro-aza-Michael reaction, with the subsequent racemization of the chiral center. Therefore, this reaction was optimized (see the Supporting Information for details), and we found that, after compound 3a had been heated with 2.5 equiv of Petasis reagent in toluene at 95 °C for 4 h, methylenation product 4a was obtained in 56% isolated yield (Scheme 4, eq 2). Then, this compound was subjected to the RCM reaction, and after some optimization of the conditions (see the Supporting Information for details), we were able to isolate monofluorinated indolizidinone derivative 5a in a noticeable 53% yield by heating compound 4a in a highly diluted solution of toluene (0.005 M) at 105 °C for 48 h in the presence of the Hoveyda–Grubbs second-generation catalyst (HG-II) (Scheme 4, eq 3). It is important to mention that this RCM reaction generated a fluorine-containing tetrasubstituted double bond, which is a quite challenging task, given that cyclizations through RCM are very sensitive to steric issues.
On the contrary, during the purification of pyrrolidine 4a, we observed that it was a volatile and unstable compound. For this reason, and to improve the efficiency of the process, we decided to evaluate the sequence of methylenation/RCM in a one-pot manner. Thus, when the reaction of 4a with Petasis reagent had reached completion (determined by TLC analysis of the crude reaction mixture), titanium salts were filtered off and the resulting residue was directly treated with the HG-II catalyst and heated for 48 h at 105 °C. Under these conditions, the desired indolizidine derivative 5a was isolated in 45% overall yield, indicating that the one-pot procedure is more efficient than the stepwise protocol (Scheme 4, eq 4). Importantly, chiral HPLC analysis of product 5a (95% ee) showed no erosion of the stereochemical integrity of the stereocenter generated during the organocatalytic IMAMR step.
The optimized conditions for the one-pot sequence methylenation/RCM reaction were then applied to the rest of chiral pyrrolidines 3 (Scheme 5). While substrate 3a bearing a methyl ketone rendered indolizidine derivative 5a in 45% overall yield, the analogous propyl and pentyl ketones rendered the corresponding fluorinated products 5b and 5c in 25% and 24% yields, respectively, indicating that the increase in the steric requirements made the RCM reaction more difficult. In this context, aromatic ketone 3d led to compound 5d in trace amounts. Spirocyclic substrates 3e–j allowed the synthesis of indolizidine derivatives 5e–j, respectively, in valuable yields ranging from 33% to 51%. Likewise, the nonsubstituted substrate with five-membered ring 3k and gem-diphenyl compound 3l provided the corresponding indolizidinones 5k and 5l, respectively, in moderate yields (30% and 33%, respectively). Benzo-fused derivatives 5m–o were also successfully obtained in comparable yields (31–42%), as well as trifluoromethyl compound 5p (40% yield). In all cases, the stereochemical integrity of the carbon stereocenter was preserved and no erosion of enantiopurity was detected (Scheme 5).
Scheme 5. Synthesis of Fluorinated Indolizidine Derivatives 5 by the Methylenation/RCM Sequence–
Reactions were carried out with 3 (0.1–0.3 mmol) and Cp2TiMe2 (2.5 equiv) in toluene (0.1 M) at 95 °C for 4 h. RCM was performed with HG-II (10 mol %) in toluene (0.005 M) at 105 °C for 48 h.
Isolated yields after flash column chromatography.
Enantiomeric ratios were determined by HPLC analysis on a chiral stationary phase (see the Supporting Information for details).
The whole synthesis of fluorinated indolizidinone 5a was tested on a multigram scale. Thus, starting from 1.48 g of fluorinated amide 1a (8 mmol), 540 mg of indolizidinone 5a was obtained; i.e., this product was formed in 34% overall yield in four reaction steps without erosion of the ee value.
Finally, compound (±)-5a was derivatized to the corresponding indolizidinone through hydrogenation of the double bond. Treatment of (±)-5a with Pd/C in ethyl acetate under a hydrogen atmosphere for 24 h afforded indolizidinone (±)-7 in 66% yield as a single diastereoisomer (Scheme 6). The relative disposition of the newly created stereocenters was determined by X-ray analysis.18
Scheme 6. Hydrogenation of Compound (±)-5a.
In conclusion, the enantioselective organocatalytic synthesis of a family of fluorinated indolizidinone derivatives has been described. Conjugated fluorinated amides 1 bearing a pendant olefin were subjected to the CM/IMAMR/methylenation/RCM sequence to render imidazolidinone derivatives 5 in synthetically useful overall yields and good enantioselectivities. A chiral sterocenter was efficiently generated with the participation of (S)-TRIP-derived phosphoric acid as the catalyst. Then, carbonyl methylenation with Petasis reagent followed by RCM with the Hoveyda–Grubbs second-generation catalyst occurred without erosion of the stereochemical integrity of the chiral center after both processes.
Acknowledgments
The authors thank the Spanish Ministerio de Ciencia e Innovación (PID2020-115294GB-I00 to C.d.P.) for financial support. M.E. and D.G. thank the Spanish Ministerio de Educación, Cultura y Deporte for predoctoral fellowships (FPU16/04533 and FPU18/02750). Technical and human support provided by IZO-SGI SGIker of UPV/EHU is gratefully acknowledged. SCSIE and ICTS NANBIOSIS U26 (Universidad de Valencia) are gratefully acknowledged for the equipment employed.
Data Availability Statement
The data underlying this study are available in the published article and its Supporting Information.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.orglett.3c00903.
The authors declare no competing financial interest.
Dedication
Dedicated to Prof. Dennis Curran on the occasion of his 70th birthday.
Supplementary Material
References
- a Zhang J.; Morris-Natschke S. L.; Ma D.; Shang X. F.; Yang C. J.; Liu Y. Q.; Lee K. H. Biologically Active Indolizidine Alkaloids. Med. Res. Rev. 2021, 41, 928. 10.1002/med.21747. [DOI] [PubMed] [Google Scholar]; b Sharma V.; Kamal R.; Kumar D.; Kumar V. Indolizidine Alkaloids. Prospective Lead Molecules in Medicinal Chemistry. Curr. Tradit. Med. 2021, 7, 45. 10.2174/2215083805666190617145228. [DOI] [Google Scholar]; c Kim E.; Lee Y.; Lee S.; Park S. B. Discovery, Understanding, and Bioapplication of Organic Fluorophore: a Case Study with an Indolizine-Based Novel Fluorophore, Seoul-fluor. Acc. Chem. Res. 2015, 48, 538. 10.1021/ar500370v. [DOI] [PubMed] [Google Scholar]; d Sharma V.; Kumar V. Indolizine: a Biologically Active Moiety. Med. Chem. Res. 2014, 23, 3593. 10.1007/s00044-014-0940-1. [DOI] [Google Scholar]; e Singh G. S.; Mmatli E. E. Recent Progress in Synthesis and Bioactivity Studies of Indolizines. Eur. J. Med. Chem. 2011, 46, 5237. 10.1016/j.ejmech.2011.08.042. [DOI] [PubMed] [Google Scholar]
- For recent reviews of the synthesis of indolizidine scaffolds, see:; a Frǎnová P.; Marchalín Š. Recent Developments in the Synthesis of Polyhydroxylated Indolizidines. Eur. J. Org. Chem. 2022, 2022, e202200742 10.1002/ejoc.202200742. [DOI] [Google Scholar]; b Ratmanova N. K.; Andreev I. A.; Leontiev A. V.; Momotova D.; Novoselov A. M.; Ivanova O. A.; Trushkov I. V. Strategic Approaches to the Synthesis of Pyrrolizidine and Indolizidine Alkaloids. Tetrahedron 2020, 76, 131031. 10.1016/j.tet.2020.131031. [DOI] [Google Scholar]; c Nájera C.; Sansano J. M. Synthesis of Pyrrolizidines and Indolizidines by Multicomponent 1,3-Dipolar Cycloaddition of Azomethine Ylides. Pure Appl. Chem. 2019, 91, 575. 10.1515/pac-2018-0710. [DOI] [Google Scholar]; d Davies S. G.; Fletcher A. M.; Roberts P. M.; Thomson J. E. Asymmetric Synthesis of Pyrrolizidines, Indolizidines and Quinolizidines via a Double Reductive Cyclisation Protocol. Synlett 2017, 28, 2697. 10.1055/s-0036-1590975. [DOI] [Google Scholar]; e Sadowski B.; Klajn J.; Gryko D. T. Recent Advances in the Synthesis of Indolizines and their π-Expanded Analogues. Org. Biomol. Chem. 2016, 14, 7804. 10.1039/C6OB00985A. [DOI] [PubMed] [Google Scholar]; f Michael J. P.Chapter One - Simple Indolizidine and Quinolizidine Alkaloids. In The Alkaloids: Chemistry and Biology; Knölker H.-J., Ed.; Academic Press, 2016; Vol. 75, pp 1–498. [DOI] [PubMed] [Google Scholar]; g Michael J. P. Indolizidine and Quinolizidine Alkaloids. Nat. Prod. Rep. 2008, 25, 139.and references cited therein 10.1039/B612166G. [DOI] [PubMed] [Google Scholar]
- a Meanwell N. A. Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. J. Med. Chem. 2018, 61, 5822. 10.1021/acs.jmedchem.7b01788. [DOI] [PubMed] [Google Scholar]; b Gillis E. P.; Eastman K. J.; Hill M. D.; Donnelly D. J.; Meanwell N. A. Applications of Fluorine in Medicinal Chemistry. J. Med. Chem. 2015, 58, 8315. 10.1021/acs.jmedchem.5b00258. [DOI] [PubMed] [Google Scholar]; c Swallow S. Fluorine in medicinal chemistry. Prog. Med. Chem. 2015, 54, 65. 10.1016/bs.pmch.2014.11.001. [DOI] [PubMed] [Google Scholar]; d Purser S.; Moore P. R.; Swallow S.; Gouverneur V. Fluorine in Medicinal Chemistry. Chem. Soc. Rev. 2008, 37, 320. 10.1039/B610213C. [DOI] [PubMed] [Google Scholar]
- a Zhang C. Fluorine in Medicinal Chemistry. In Perspective to COVID-19. ACS Omega 2022, 7, 18206. 10.1021/acsomega.2c01121. [DOI] [PMC free article] [PubMed] [Google Scholar]; b Mei H.; Han J.; Fustero S.; Medio-Simon M.; Sedgwick D. M.; Santi C.; Ruzziconi R.; Soloshonok V. A. Frontispiece: Fluorine-Containing Drugs Approved by the FDA in 2018. Chem. - Eur. J. 2019, 25, 840. 10.1002/chem.201985161. [DOI] [PubMed] [Google Scholar]; c Zhou Y.; Wang J.; Gu Z.; Wang S.; Zhu W.; Acena J. L.; Soloshonok V. A.; Izawa K.; Liu H. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. Chem. Rev. 2016, 116, 422. 10.1021/acs.chemrev.5b00392. [DOI] [PubMed] [Google Scholar]; d Wang J.; Sanchez-Rosello M.; Acena J. L.; del Pozo C.; Sorochinsky A. E.; Fustero S.; Soloshonok V. A.; Liu H. Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011). Chem. Rev. 2014, 114, 2432. 10.1021/cr4002879. [DOI] [PubMed] [Google Scholar]
- O’Hagan D. Fluorine in Health Care: Organofluorine Containing Blockbuster Drugs. J. Fluorine Chem. 2010, 131, 1071. 10.1016/j.jfluchem.2010.03.003. [DOI] [Google Scholar]
- Klipkov A. A.; Gerus I. I.; Sorochinsky A. E. Synthesis of Fluorinated Pyrrolizidine, Indolizidine and Quinolizidine Derivatives. Ukr. Bioorg. Acta 2022, 17, 22. 10.15407/bioorganica2022.01.022. [DOI] [Google Scholar]
- Okano T.; Fumoto M.; Kusukawa T.; Fujita M. Synthesis of Optically Active Trifluoromethylated Indolizidine Derivatives via Stereoselective Radical Cyclization. Org. Lett. 2002, 4, 1571. 10.1021/ol025792b. [DOI] [PubMed] [Google Scholar]
- Kim G.; Kim N. Hydrogenation Condition for Sequential Processes to (+)-Trifluoromethyl Monomorine. Tetrahedron Lett. 2005, 46, 423. 10.1016/j.tetlet.2004.11.094. [DOI] [Google Scholar]
- Thaharn W.; Bootwicha T.; Soorukram D.; Kuhakarn C.; Prabpai S.; Kongsaeree P.; Tuchinda P.; Reutrakul V.; Pohmakotr M. Asymmetric Synthesis of gem-Difluoromethylenated Dihydroxypyrrolizidines and Indolizidines. J. Org. Chem. 2012, 77, 8465. 10.1021/jo301327s. [DOI] [PubMed] [Google Scholar]
- Korvorapun K.; Soorukram D.; Kuhakarn C.; Tuchinda P.; Reutrakul V.; Pohmakotr M. Stereoselective Nucleophilic Addition of PhSCF2SiMe3 to Chiral Cyclic Nitrones: Asymmetric Synthesis of gem-Difluoromethylenated Polyhydroxypyrrolizidines and- indolizidines. Chem. - Asian J. 2015, 10, 948. 10.1002/asia.201403023. [DOI] [PubMed] [Google Scholar]
- Marhold M.; Stillig C.; Fröhlich R.; Haufe G. Ring-Closing Metathesis of Vinyl Fluorides towards α-Fluorinated α,β-Unsaturated Lactams and Lactones. Eur. J. Org. Chem. 2014, 2014, 5777. 10.1002/ejoc.201402535. [DOI] [Google Scholar]
- Cordero F. M.; Vurchio C.; Faggi C.; Brandi A. Configuration-Guided Reactions: the Case of highly Decorated Spiro[cyclopropane-1,2’(3′H)-pyrrolo[1,2-b]isoxazole] Derivatives en Route to Polyhydroxyindolizidines. Org. Chem. Front. 2016, 3, 1651. 10.1039/C6QO00410E. [DOI] [Google Scholar]
- a Escolano M.; Guerola M.; Torres J.; Gaviña D.; Alzuet-Piña G.; Sánchez-Roselló M.; del Pozo C. Organocatalytic Enantioselective Synthesis of 2,5,5-Trisubstituted Piperidines Bearing a Quaternary Stereocenter. Vinyl Sulfonamide as a New Amine Protecting Group. Chem. Commun. 2020, 56, 1425. 10.1039/C9CC09113K. [DOI] [PubMed] [Google Scholar]; b Mulet C.; Escolano M.; Llopis S.; Sanz S.; Ramirez de Arellano C.; Sánchez-Roselló M.; Fustero S.; del Pozo C. Dual Role of Vinyl Sulfonamides as N-Nucleophiles and Michael Acceptors in the Enantioselective Synthesis of Bicyclic δ-Sultams. Adv. Synth. Catal. 2018, 360, 2885. 10.1002/adsc.201800548. [DOI] [Google Scholar]; c Fustero S.; del Pozo C.; Mulet C.; Lázaro R.; Sánchez-Roselló M. Microwave-Assisted Organocatalytic Enantioselective Intramolecular aza-Michael Reaction with α,β-Unsaturated Ketones. Chem. - Eur. J. 2011, 17, 14267. 10.1002/chem.201101292. [DOI] [PubMed] [Google Scholar]
- Escolano M.; Torres-Fernández J.; Rabasa-Alcañiz F.; Sánchez-Roselló M.; del Pozo C. Enantioselective Synthesis of Pyrrolizidinone Scaffolds through Multiple-Relay Catalysis. Org. Lett. 2020, 22, 9433. 10.1021/acs.orglett.0c03344. [DOI] [PubMed] [Google Scholar]
- For selected reviews of chiral CPAs, see:; a Akiyama T. Stronger Brønsted Acids. Chem. Rev. 2007, 107, 5744. 10.1021/cr068374j. [DOI] [PubMed] [Google Scholar]; b Terada M. Binaphthol-Derived Phosphoric Acid as a Versatile Catalyst for Enantioselective Carbon-Carbon Bond Forming Reactions. Chem. Commun. 2008, 4097. 10.1039/b807577h. [DOI] [PubMed] [Google Scholar]; c Parmar D.; Sugiono E.; Raja S.; Rueping M. Complete Field Guide to Asymmetric BINOL-Phosphate Derived Brønsted Acid and Metal Catalysis: History and Classification by Mode of Activation; Bronsted Acidity, Hydrogen Bonding, Ion Pairing, and Metal Phosphates. Chem. Rev. 2014, 114, 9047. 10.1021/cr5001496. [DOI] [PubMed] [Google Scholar]; d Akiyama T.; Mori K. Stronger Brønsted Acids: Recent Progress. Chem. Rev. 2015, 115, 9277. 10.1021/acs.chemrev.5b00041. [DOI] [PubMed] [Google Scholar]; e Maji R.; Mallojjala S. C.; Wheeler S. E. Chiral Phosphoric Acid Catalysis: from Numbers to Insights. Chem. Soc. Rev. 2018, 47, 1142. 10.1039/C6CS00475J. [DOI] [PubMed] [Google Scholar]
- CCDC 2247118 contains the supplementary crystallographic data for compound 3p. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
- a Hartley R. C.; Li J.; Main C. A.; McKiernan G. J. Titanium Carbenoid Reagents for Converting Carbonyl Groups into Alkenes. Tetrahedron 2007, 63, 4825. 10.1016/j.tet.2007.03.015. [DOI] [Google Scholar]; b Petasis N.; Bzowej E. Titanium-mediated carbonyl olefinations. 1. Methylenations of Carbonyl Compounds with Dimethyltitanocene. J. Am. Chem. Soc. 1990, 112, 6392. 10.1021/ja00173a035. [DOI] [Google Scholar]
- CCDC 2247169 contains the supplementary crystallographic data for compound 7. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data underlying this study are available in the published article and its Supporting Information.







